Rein Therapeutics, Inc. (NASDAQ:RNTX) IPO
IPO
Went public as AILERON THERAPEUTICS INC. Priced at US$15.00 a share on Jun 28, 2017.
- Price
- US$15.00 a share
- Shares offered
- 3,750,000 shares of common stock
- Offering size
- US$56.3 million
- Underwriters' option
- Up to 562,500 more shares
- Underwriters
- BofA Merrill Lynch, Jefferies, William Blair, Canaccord Genuity · In the order on the cover
- Shares delivered
- On or about Jul 5, 2017
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 10, 2015 |
| Filed publicly | Jun 2, 2017 |
| Amended once | Jun 19, 2017 |
| Shares registered with an exchange | Jun 23, 2017 |
| Declared effective by the SEC | Jun 28, 2017 |
| Final prospectus, with the price | Jun 29, 2017 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 29, 2017 |
| EFFECT · Notice that a registration is effective | Jun 28, 2017 |
| CORRESP · Letter to the SEC | Jun 26, 2017 |
| CORRESP · Letter to the SEC | Jun 26, 2017 |
| CERTNAS · Nasdaq's certificate of listing | Jun 23, 2017 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 23, 2017 |
| CORRESP · Letter to the SEC | Jun 19, 2017 |
| S-1/A · Registration statement, amended | Jun 19, 2017 |
| CORRESP · Letter to the SEC | Jun 7, 2017 |
| S-1 · Registration statement | Jun 2, 2017 |
| DRSLTR · Letter to the SEC with a draft | May 26, 2017 |
| DRS/A · Draft registration statement, amended | May 26, 2017 |
| UPLOAD · Letter from the SEC | May 12, 2017 |
| DRS/A · Draft registration statement, amended | Apr 17, 2017 |
| DRS/A · Draft registration statement, amended | Mar 28, 2016 |
| DRS/A · Draft registration statement, amended | Dec 29, 2015 |
| DRSLTR · Letter to the SEC with a draft | Dec 29, 2015 |
| UPLOAD · Letter from the SEC | Oct 5, 2015 |
| DRS · Draft registration statement | Sep 10, 2015 |
From the cover of the final prospectus (424B4) filed Jun 29, 2017